NCT02971618View on ClinicalTrials.gov

Study With Dapagliflozin

CompletedOBSERVATIONAL

Enrollment

929

Participants

Timeline

Start Date

February 21, 2017

Primary Completion Date

August 3, 2018

Study Completion Date

August 3, 2018

Conditions

Diabetes Mellitus Type 2

Trial Locations (2)

Unknown

Research Site, Moscow

Research Site, Saint Petersburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY